Invion Formulates Nadolol to Aid in Smoking Cessation
Chronic Bronchitis, COPD
Invion, Inc. is currently enrolling 136 patients with chronic obstructive pulmonary disease (COPD) for a Phase 2 clinical trial evaluating its drug INV102 (nadolol). The goal of the study is ... Read more